Managing chronic hepatitis C virus infection.
- 20 February 1993
- Vol. 306 (6876), 469-470
- https://doi.org/10.1136/bmj.306.6876.469
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infectionJournal of Hepatology, 1993
- Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCVThe Lancet, 1992
- Effect of Interferon-a2b on Cryoglobulinemia Related to Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 1992
- Recombinant Interferon- for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1992
- Improved Serodiagnosis of Posttransfusion Hepatitis C Virus Infection by a Second‐Generation Immunoassay Based on Multiple Recombinant AntigensVox Sanguinis, 1992
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Ribavirin treatment for chronic hepatitis CThe Lancet, 1991
- Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assayThe Lancet, 1991
- Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitisThe Lancet, 1991
- PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1989